3. Tsioufis CP, Stefanadis CI,Toutouzas PK. Images in cardiology:Preoperative treatmentwith phenoxybenzaminerestores ECG to normalin a woman with pheochromocytoma.Heart. 2002Aug;88(2):186.4. Desmonts JM, le Houelleur J,Remond P, et al. Anaestheticmanagement of patients withphaeochromocytoma: Areview of 102 cases. Br JAnaesth 49:991, 1977.5. Boutros AR, Bravo EL,Zanettin G, Straffon RA.Perioperative management of63 patients with pheochromocytoma.Cleve Clin J Med.1990 Oct;57(7):613-7.6. Witteles RM, Kaplan EL,Roizen MF. Safe and cost–effective preparation of patientswith phaeochromocytoma.Anesth Analg 91:302-4,2000.7. Oberoi GS, Yaubihi N,Clezy JK. Anaesthesia forphaeochromocytoma resection:role of thoracic epiduralblockade. P N G Med J.1993 Dec;36(4):301-5.8. Russell WJ, Metcalfe IR,Tonkin AL, Frewin DB. Thepreoperative management ofphaeochromocytoma.Anaesth Intensive Care. 1998Apr;26(2):196-200.9. Hamilton A, Sirrs S, SchmidtN, Onrot J. Anaesthesia forphaeochromocytoma inpregnancy. Can J Anaesth.1997 Jun;44(6):654-7.10. James MF, Huddle KR, OwenAD, van der Veen BW. Useof magnesium sulphate in theanaesthetic management ofphaeochromocytoma inpregnancy. Can J Anaesth.1988 Mar;35(2):178-82.11. Hack HA, Brown TC.Preoperative management ofphaeochromocytoma—apaediatric perspective.Anaesth Intensive Care. 1999Feb;27(1):112-3.Side Effects of NitrousOxideNitrous oxide has no smell andis not unpleasant to breathe. Themask may smell a little rubberybut this is not usually unpleasant.Some people have a ‘phobia’ forface masks and feel as thoughthey are suffocating. (Such fearsoften go back to a previous unpleasantexperience; for example,in the dentist’s chair! ) If so, manypeople prefer to breathe throughthe mouth piece insteadNot everyone likes the effects ofnitrous oxide. Some people feelthat is makes them feels nauseated(although this occurs commonlyin labour anyway). Othersfeel confused or disoriented,floating, or a bit drunk. Thesefeelings are pleasant for some,but unpleasant for others. Theimportant thing to remember isthat all of these effects willquickly disappear once you stopusing it. If they don’t - then somethingelse must be to blame, suchas stress or fatigueThere is absolutely no risk of becomingdependent or addicted tonitrous oxide when using it duringchildbirth. If it is used in highconcentrations for a very longtime, nitrous oxide can depressthe bone marrow and lead totemporary anaemia. For this tooccur, the exposure period needsto be at least eight hours (and atconcentrations sufficient to produceanaesthesia). There is noevidence that this complicationhas ever occurred -or even couldoccur - using nitrous oxide duringchildbirth.Effects on the BabyNitrous oxide does not cause anyabnormalities or malformations.Nor does it interfere with thecontractions or have any effecton the duration of labour. Althoughit passes easily to the baby,as we have already seen, it is veryrapidly eliminated as soon as thebaby cries and starts to breathe.It does not have any effect on thefetal heart rate or circulation anddoes not depress the baby’s respirationat birth. In other words,nitrous oxide is perfectly safe forthe baby.Studies on the neurobehaviour ofinfants who have been exposedto nitrous oxide during labourhave detected no influence of thegas whatsoever - even in the firstfew hours of life. Similarly, otherstudies have confirmed that nitrousoxide has no effects on theinfant’s ability to suckle.68Journal of Postgraduate Medical Education, Training & ResearchVol. II, No. 5, September-October 2007
11ReviewArticleMyasthenia Gravis and Anaesthetic ImplicationsRavinder Kumar Batra, Kajari RoyDepartment of Anaesthesiology, All India Institute of Medical Sciences, New DelhiMyasthenia gravis is anautoimmune disease,with an incidence of0.25 to 2.0 per 100,000 people,resulting from the production ofantibodies against the alphasubunit of nicotinic acetylcholinereceptors of the endplate 1, 2, 3, 4 .These antibodies reduce thenumber of active receptors,brought about either byfunctional block of the receptors,by increased rate of receptordegradation, or by complementmediatedlysis. Repetitive nervestimulation results in adecremental response. Thedisease is frequently associatedwith morphologic alabnormalitiesof the thymus 5 . In youngpatients, thymic hyperplasia iscommon while thymoma is morefrequent in elderly patients.Myasthenia gravis may beassociated with other disordersof autoimmune origin suchas thyroid hypofunction,rheumatoid arthritis, andsystemic lupus erythematosus.Clinical presentationsl Transient neonatal myasthenia- It is present in 20% ofneonates born to myasthenicmothers, with difficulty insucking and swallowing, difficultywith breathing, ptosisand facial weakness. The conditionhas a tendency to spontaneousremission, usuallywithin two to four weeks.l Congenital or infantilemyasthenia-These childrenhave variable muscleweakness from birth dueto congenital endplateacetylcholine-receptordeficiency.The condition isnot autoimmune in nature,and hence therapy primarilydepends on anticholinesterasetherapy.l Juvenile myasthenia-This issimilar in pathogenesis andtreatment to the adult variety,except that thymoma is not afeature in these cases.l Adult Myasthenia Gravis(MG)-The incidence is about1 in every 20,000 adults.There is a preponderance ofwomen, Hyperplasia of thethymus gland is present inover 70% of patients, and 10-15% have thymomas. Theclinical course of MG ismarked by periods ofexacerbations and remissions.History & Clinical examination- The extraocular musclesare involved at some time in thecourse of the disease in almostevery patient during the first year.Weakness of pharyngeal and laryngealmuscles (bulbar muscles)results in dysphagia and dysarthria.Arm, leg, or truncal weaknesscan occur in any combinationand is usually asymmetricalin distribution. After the diseasereaches its maximum severity,most patients who survive continuewith a chronic form of thedisease with fewer and less severeepisodes of exacerbation.A detailedcentral nervous system examinationshould be performed.This will show normal highermental functions and unalteredsensory system function. A motorsystem examination enablesthe anaesthesiologist to gauge theseverity of the disease process,and this shows involvement ofthe lower cranial nerves and anasymmetrical muscle involvementin the rest of the body.Classification <strong>Of</strong> MyastheniaGravis(Ossermann andGenkins)I Ocular signs and symptomsonlyII A Generalized mildmuscle weaknessIIB Generalized moderateweakness, and/or bulbardysfunctionIII Acute fulminating presentation,and/or respiratorydysfunctionIV Late severe generalizedmyasthenia gravisThe distribution, severity, andoutcome of the disease aredetermined during the first oneto three years after the onset. In14%, the disease remainsclinically localized to extraocularmuscles and in the remaining86%, becomes generalized.Journal of Postgraduate Medical Education, Training & Research69
- Page 1:
Global Phenomenon of e-healthP.S. S
- Page 4 and 5:
Basic Life SupportRavinder Kumar Ba
- Page 6 and 7:
age 5 . AHA recommends abdominalthr
- Page 8 and 9:
ficult when bleeding is brisk, andi
- Page 10 and 11:
orrhage, a non-bleeding visiblevess
- Page 12 and 13:
structures visualized with nakedeye
- Page 14 and 15:
LSCS is taken, patient shouldbe kep
- Page 16 and 17:
in amniotic fluid), nor due to apre
- Page 18 and 19: l Reduction in induction-deliveryin
- Page 20 and 21: to the blood pressure changes.l Hyp
- Page 22 and 23: incidence of side-effects andPONV.
- Page 24 and 25: 2. Nasal injectionThe same needle i
- Page 26 and 27: injected. It blocks sensation fromt
- Page 28 and 29: Intraocular tumorsIn children, reti
- Page 30 and 31: A fast of six to eight hours forsol
- Page 32 and 33: lControl ventilation should beiniti
- Page 34 and 35: 6ReviewArticleAnaesthesia for Nonca
- Page 36 and 37: immunosuppression, andpreoperative
- Page 38 and 39: and the most frequent andimportant
- Page 40 and 41: ppressive drugs or chronic heartfai
- Page 42 and 43: 7ReviewArticleAnticoagulants and An
- Page 44 and 45: The dose of heparin varies withthe
- Page 46 and 47: and has a half -life of 24-48 hours
- Page 48 and 49: llPatients receiving heparin forgre
- Page 50 and 51: (5%). For patients with mitralprost
- Page 52 and 53: Cardiovascularl Hypertension- Over
- Page 54 and 55: elaxants, and provides goodpost-ope
- Page 56 and 57: l(CK-MB), and troponin. TotalCK lev
- Page 58 and 59: 9ReviewArticleObesity and Anesthesi
- Page 60 and 61: yet to be validated and should be u
- Page 62 and 63: prior to induction followed byPEEP
- Page 64 and 65: Anesthetic Implications-Thepreferre
- Page 66 and 67: Excretion of catecholamines and the
- Page 70 and 71: Diagnosisl Edrophonium (Tensilontes
- Page 72 and 73: erases may increase the needfor non
- Page 74 and 75: 2. Drachman DB. Myastheniagravis. N
- Page 76 and 77: ecommended to control psychoticsymp
- Page 78 and 79: espiratory complications due tothe
- Page 80 and 81: pain and a sensation of fullnessin
- Page 82 and 83: gastrointestinal stromaltumors: rec
- Page 84 and 85: 13Many new supraglotticairway devic
- Page 86 and 87: to the cuff size of the originalLMA
- Page 88 and 89: LMAs with valves that do notcontain
- Page 90 and 91: geal mask airway in paralyzed,anest
- Page 92 and 93: Foregger Midget) and diffusionof su
- Page 94 and 95: cause serious problems. Longersurge
- Page 96 and 97: positioning accuracy for CTguided s
- Page 98 and 99: decreases with increased optodesepa
- Page 100 and 101: observed that SJO 2of 50% ingeneral
- Page 102 and 103: ibility of cerebral circulatory arr
- Page 104 and 105: investigation and suggests thatesta
- Page 106: 14. Kiening ML, Unterberg AW,Bard T